FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980592165> ?p ?o ?g. }

• W2980592165 endingPage "561" @default.
• W2980592165 startingPage "561" @default.
• W2980592165 abstract "Vascular remodeling, that contributes to cardiovascular diseases such as hypertension develops by anomalous proliferation and migration of vascular smooth muscle cells (VSMCs). Cortistatin (CST), a newly discovered biological peptide, has been acknowledged for its protective effects against cardiovascular diseases. Whether CST has an inhibitory regulation role in angiotensin II (Ang II)-induced proliferation and migration of VSMCs and what molecular mechanisms may participate in the CST inhibition process are still unknown.VSMCs were divided into control group, Ang II (10-7 M) group, Ang II + PD98059 (5×10-5 M) group, Ang II + SB203580 (10-5 M) group, Ang II + SP600125 (10-5 M) group, Ang II + XMD17-109 (10-6 M) group, Ang II + CST (10-8 M) group and Ang II + CST (10-7 M) group. Cell proliferation was detected by western blotting and cell counting kit-8 (CCK8) analysis. Migration of VSMCs was measured by Transwell assay.Compared with control group, Ang II upregulated the expression levels of proliferating cell nuclear antigen (PCNA) and osteopontin (OPN) and downregulated that of α-smooth muscle actin (α-SMA), increased the proliferation rate as shown by CCK8 and VSMC migration as shown by Transwell assay in cultured VSMCs of the Ang II group. Meanwhile, in Ang II-cultured VSMCs, we found activation of extracellular signal-regulated kinase (ERK) 1/2, p38 MAP kinase (p38 MAPK), c-Jun N-terminal kinase (JNK), and ERK5 pathways by western blotting at different time points. However, the proliferation and migration stimulated by Ang II were partly reversed by drug inhibitors of the four pathways, namely, PD98059, SB203580, SP600125 and XMD17-109. When Ang II-stimulated VSMCs were cultured with CST pretreatment, we found that proliferation and migration were greatly suppressed as well as that the ERK1/2, p38 MAPK, JNK and ERK5 pathways were deactivated by CST.The accumulated data suggest that CST may play a protective role in Ang II-promoted proliferation and migration of VSMCs via inhibiting the mitogen-activated protein kinase (MAPK) family pathways, providing a new orientation of CST in protecting against cardiovascular diseases." @default.
• W2980592165 created "2019-10-25" @default.
• W2980592165 creator A5001937247 @default.
• W2980592165 creator A5007999482 @default.
• W2980592165 creator A5018077929 @default.
• W2980592165 creator A5028451638 @default.
• W2980592165 creator A5028907260 @default.
• W2980592165 creator A5037172649 @default.
• W2980592165 creator A5039629749 @default.
• W2980592165 creator A5045545412 @default.
• W2980592165 creator A5049644175 @default.
• W2980592165 creator A5064842058 @default.
• W2980592165 creator A5066703722 @default.
• W2980592165 creator A5080656447 @default.
• W2980592165 creator A5086147269 @default.
• W2980592165 creator A5090528463 @default.
• W2980592165 creator A5091620323 @default.
• W2980592165 date "2019-10-01" @default.
• W2980592165 modified "2023-09-27" @default.
• W2980592165 title "Cortistatin exerts antiproliferation and antimigration effects in vascular smooth muscle cells stimulated by Ang II through suppressing ERK1/2, p38 MAPK, JNK and ERK5 signaling pathways" @default.
• W2980592165 cites W1873908353 @default.
• W2980592165 cites W1884330892 @default.
• W2980592165 cites W1978210210 @default.
• W2980592165 cites W1984120481 @default.
• W2980592165 cites W1996016792 @default.
• W2980592165 cites W2002768097 @default.
• W2980592165 cites W2024946584 @default.
• W2980592165 cites W2047992631 @default.
• W2980592165 cites W2048242167 @default.
• W2980592165 cites W2068125593 @default.
• W2980592165 cites W2076216271 @default.
• W2980592165 cites W2091507377 @default.
• W2980592165 cites W2092218209 @default.
• W2980592165 cites W2092555227 @default.
• W2980592165 cites W2106059849 @default.
• W2980592165 cites W2120322843 @default.
• W2980592165 cites W2138982605 @default.
• W2980592165 cites W2156835140 @default.
• W2980592165 cites W2160226460 @default.
• W2980592165 cites W2160539191 @default.
• W2980592165 cites W2301367998 @default.
• W2980592165 cites W2342346488 @default.
• W2980592165 cites W2385391919 @default.
• W2980592165 cites W2476242005 @default.
• W2980592165 cites W2549218357 @default.
• W2980592165 cites W2764162380 @default.
• W2980592165 cites W2772238885 @default.
• W2980592165 cites W2790906215 @default.
• W2980592165 doi "https://doi.org/10.21037/atm.2019.09.45" @default.
• W2980592165 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6861776" @default.
• W2980592165 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31807542" @default.
• W2980592165 hasPublicationYear "2019" @default.
• W2980592165 type Work @default.
• W2980592165 sameAs 2980592165 @default.
• W2980592165 citedByCount "26" @default.
• W2980592165 countsByYear W29805921652020 @default.
• W2980592165 countsByYear W29805921652021 @default.
• W2980592165 countsByYear W29805921652022 @default.
• W2980592165 countsByYear W29805921652023 @default.
• W2980592165 crossrefType "journal-article" @default.
• W2980592165 hasAuthorship W2980592165A5001937247 @default.
• W2980592165 hasAuthorship W2980592165A5007999482 @default.
• W2980592165 hasAuthorship W2980592165A5018077929 @default.
• W2980592165 hasAuthorship W2980592165A5028451638 @default.
• W2980592165 hasAuthorship W2980592165A5028907260 @default.
• W2980592165 hasAuthorship W2980592165A5037172649 @default.
• W2980592165 hasAuthorship W2980592165A5039629749 @default.
• W2980592165 hasAuthorship W2980592165A5045545412 @default.
• W2980592165 hasAuthorship W2980592165A5049644175 @default.
• W2980592165 hasAuthorship W2980592165A5064842058 @default.
• W2980592165 hasAuthorship W2980592165A5066703722 @default.
• W2980592165 hasAuthorship W2980592165A5080656447 @default.
• W2980592165 hasAuthorship W2980592165A5086147269 @default.
• W2980592165 hasAuthorship W2980592165A5090528463 @default.
• W2980592165 hasAuthorship W2980592165A5091620323 @default.
• W2980592165 hasBestOaLocation W29805921651 @default.
• W2980592165 hasConcept C104317684 @default.
• W2980592165 hasConcept C126322002 @default.
• W2980592165 hasConcept C127561419 @default.
• W2980592165 hasConcept C132149769 @default.
• W2980592165 hasConcept C134018914 @default.
• W2980592165 hasConcept C137738243 @default.
• W2980592165 hasConcept C1491633281 @default.
• W2980592165 hasConcept C170493617 @default.
• W2980592165 hasConcept C184235292 @default.
• W2980592165 hasConcept C185592680 @default.
• W2980592165 hasConcept C2779395532 @default.
• W2980592165 hasConcept C2780804394 @default.
• W2980592165 hasConcept C2908929049 @default.
• W2980592165 hasConcept C2992686903 @default.
• W2980592165 hasConcept C51551487 @default.
• W2980592165 hasConcept C55493867 @default.
• W2980592165 hasConcept C57074206 @default.
• W2980592165 hasConcept C62112901 @default.
• W2980592165 hasConcept C62478195 @default.
• W2980592165 hasConcept C71924100 @default.
• W2980592165 hasConcept C85265743 @default.
• W2980592165 hasConcept C86803240 @default.

• next